APOC3 and hypertriglyceridemia: Additionally, transgenic and knockout mouse models have reinforced these findings, demonstrating that APOC3 overexpression induces hypertriglyceridemia, whereas its absence promotes efficient lipid clearance and a favourable cardiovascular profile [8,9].